This guidance update reflects changes made to the required data elements for reporting as well as the cadence with which these elements need to be reported to CDC’s National Healthcare Safety Network (NHSN) following the expiration of the federal COVID-19 public health emergency declaration. There are no significant changes or additions to the reporting questions as a result of this guidance update. Information on reporting to NHSN can be found here: https://www.cdc.gov/nhsn/covid19/hospital-reporting.html.

This dataset tracks the updates made on the dataset "COVID Hospital Data Reporting Guidance Post-PHE" as a repository for previous versions of the data and metadata.

Covid-19 Daily metrics at the county level As of 6/1/2023, this data set is no longer being updated. The COVID-19 Data Report is posted on the Open Data Portal every day at 3pm. The report uses data from multiple sources, including external partners; if data from external partners are not received by 3pm, they are not available for inclusion in the report and will not be displayed. Data that are received after 3pm will still be incorporated and published in the next report update. The cumulative number of COVID-19 cases (cumulative_cases) includes all cases of COVID-19 that have ever been reported to DPH. The cumulative number of COVID_19 cases in the last 7 days (cases_7days) only includes cases where the specimen collection date is within the past 7 days. While most cases are reported to DPH within 48 hours of specimen collection, there are a small number of cases that routinely are delayed, and will have specimen collection dates that fall outside of the rolling 7 day reporting window. Additionally, reporting entities may submit correction files to contribute historic data during initial onboarding or to address data quality issues; while this is rare, these correction files may cause a large amount of data from outside of the current reporting window to be uploaded in a single day; this would result in the change in cumulative_cases being much larger than the value of cases_7days. On June 4, 2020, the US Department of Health and Human Services issued guidance requiring the reporting of positive and negative test results for SARS-CoV-2; this guidance expired with the end of the federal PHE on 5/11/2023, and negative SARS-CoV-2 results were removed from the List of Reportable Laboratory Findings. DPH will no longer be reporting metrics that were dependent on the collection of negative test results, specifically total tests performed or percent positivity. Positive antigen and PCR/NAAT results will continue to be reportable.

Town Level COVID-19 Data As of 6/1/2023, this data set is no longer being updated. The COVID-19 Data Report is posted on the Open Data Portal every day at 3pm. The report uses data from multiple sources, including external partners; if data from external partners are not received by 3pm, they are not available for inclusion in the report and will not be displayed. Data that are received after 3pm will still be incorporated and published in the next report update. Suppression: the data in towns with fewer than five (5) cases or five (5) positive NAAT tests in the past seven (7) days are suppressed. The cumulative number of COVID-19 cases (cumulative_cases) includes all cases of COVID-19 that have ever been reported to DPH. The cumulative number of COVID_19 cases in the last 7 days (cases_7days) only includes cases where the specimen collection date is within the past 7 days. While most cases are reported to DPH within 48 hours of specimen collection, there are a small number of cases that routinely are delayed, and will have specimen collection dates that fall outside of the rolling 7 day reporting window. Additionally, reporting entities may submit correction files to contribute historic data during initial onboarding or to address data quality issues; while this is rare, these correction files may cause a large amount of data from outside of the current reporting window to be uploaded in a single day; this would result in the change in cumulative_cases being much larger than the value of cases_7days. On June 4, 2020, the US Department of Health and Human Services issued guidance requiring the reporting of positive and negative test results for SARS-CoV-2; this guidance expired with the end of the federal PHE on 5/11/2023, and negative SARS-CoV-2 results were removed from the List of Reportable Laboratory Findings. DPH will no longer be reporting metrics that were dependent on the collection of negative test results, specifically total tests performed or percent positivity. Positive antigen and PCR/NAAT results will continue to be reportable.

The Public Health Emergency (PHE) declaration for COVID-19 expired on May 11, 2023. As a result, the Aggregate Case and Death Surveillance System will be discontinued. Although these data will continue to be publicly available, this dataset will no longer be updated.

On October 20, 2022, CDC began retrieving aggregate case and death data from jurisdictional and state partners weekly instead of daily.

This dataset includes the URLs that were used by the aggregate county data collection process that compiled aggregate case and death counts by county. Within this file, each of the states (plus select jurisdictions and territories) are listed along with the county web sources which were used for pulling these numbers. Some states had a single statewide source for collecting the county data, while other states and local health jurisdictions may have had standalone sources for individual counties. In the cases where both local and state web sources were listed, a composite approach was taken so that the maximum value reported for a location from either source was used. The initial raw data were sourced from these links and ingested into the CDC aggregate county dataset before being published on the COVID Data Tracker.

Public Health England (PHE) has published the Public Health Outcomes Framework (PHOF) quarterly data update for August 2021.

The data is presented in an interactive tool that allows users to view it in a user-friendly format. The data tool also provides links to further supporting information, to aid understanding of public health in a local population.

This update contains:

• the addition of one new indicator
• one indicator updated with new methodology
• more recent data for 4 indicators

See links to indicators updated document for full details of what’s in this update.

View previous Public Health Outcomes Framework data tool updates.

Lab-confirmed case counts for England and subnational areas are provided by Public Health England and Office for National Statistics data © Crown copyright and database right 2020. All data on deaths and data for the rest of the UK are provided by the Department of Health and Social Care based on data from NHS England and the devolved administrations. This data is sourced from the UK governments Coronavirus dashboard, and thanks to code developed by Esri UK, the service will refresh when the governments dashboard is updated.To read more information such as the data collection and specific sourced, take a look at the data from the .gov.uk website here

Plug-In Hybrid Drivetrain (PHEV) Market Outlook

The global Plug-In Hybrid Drivetrain (PHEV) market size is expected to witness significant growth, with market valuations rising from USD 50 billion in 2023 to an estimated USD 150 billion by 2032, reflecting a robust CAGR of 12.5%. This impressive growth is driven by increasing consumer demand for eco-friendly transportation solutions, supportive government policies, and advancements in electric vehicle (EV) technologies.

The primary growth factor for the PHEV market is the rising awareness and concern about environmental sustainability. As global emissions regulations become stricter, there is a growing need to reduce vehicular emissions. PHEVs offer a viable solution by combining internal combustion engines with electric motors, thereby reducing the reliance on fossil fuels and lowering greenhouse gas emissions. Governments across the world are providing incentives and subsidies to encourage the adoption of PHEVs, further fueling market growth.

Technological advancements in battery technology are another significant growth driver. Over the past decade, there have been substantial improvements in battery energy density, charging speeds, and overall cost. The development of more efficient and affordable batteries has made PHEVs more attractive to consumers and automotive manufacturers alike. Companies are heavily investing in research and development to further enhance battery performance, which is expected to continue driving the market forward.

Additionally, the expansion of charging infrastructure is playing a crucial role in the growth of the PHEV market. The availability of reliable and widespread charging stations addresses one of the main concerns of potential PHEV buyers—the convenience of recharging. Governments and private entities are collaborating to build extensive charging networks, making it easier for consumers to adopt PHEVs. This growth in infrastructure support is critical for the market's expansion.

Regionally, Europe and North America are leading the charge in PHEV adoption, driven by stringent environmental regulations and government incentives. The Asia Pacific region, particularly China and Japan, is also witnessing rapid growth due to strong government support and increasing consumer awareness. Emerging markets in Latin America and the Middle East & Africa are expected to show moderate growth, supported by gradual improvements in economic conditions and infrastructure development.

Component Analysis

Battery technology is the cornerstone of the PHEV market. Advances in lithium-ion batteries have significantly improved the energy density, reducing the weight and size of battery packs while increasing their capacity. This has made PHEVs more efficient and practical for everyday use. Furthermore, ongoing research into solid-state batteries promises even greater energy densities and faster charging times, potentially revolutionizing the market. Battery recycling and second-life applications are also gaining traction, adding value to the entire lifecycle of PHEV batteries.

The electric motor is another crucial component of the PHEV drivetrain. Innovations in electric motor design have focused on increasing efficiency, reducing weight, and improving power output. The use of permanent magnet motors and advances in materials science have enabled significant performance improvements. Additionally, the integration of advanced cooling systems ensures that motors operate efficiently under various driving conditions, enhancing the overall performance of PHEVs.

Transmission systems in PHEVs are designed to optimize the power delivery from both the internal combustion engine and the electric motor. Advanced transmission technologies, such as continuously variable transmissions (CVTs) and dual-clutch transmissions (DCTs), offer seamless power transfer and improved fuel efficiency. The integration of smart control systems allows for the precise management of power flows, ensuring optimal performance and efficiency under different driving conditions.

Power electronics play a vital role in managing the flow of electricity within PHEVs. These components, including inverters, converters, and control units, are responsible for converting and regulating electrical energy from the battery to the motor and vice versa. Advances in semiconductor technology, particularly the development of silicon carbide (SiC) and gallium nitride (GaN) devices, have led to more efficient and compact power electronics. These improvements contr

These documents were produced through a collaboration between GLA, PHE London and Association of Directors of Public Health London. The wider impacts slide set pulls together a series of rapid evidence reviews and consultation conversations with key London stakeholders. The evidence reviews and stakeholder consultations were undertaken to explore the wider impacts of the pandemic on Londoners and the considerations for recovery within the context of improving population health outcomes. The information presented in the wider impact slides represents the emerging evidence available at the time of conducting the work (May-August 2020). The resource is not routinely updated and therefore further evidence reviews to identify more recent research and evidence should be considered alongside this resource. It is useful to look at this in conjunction with the ‘People and places in London most vulnerable to COVID-19 and its social and economic consequences’ report commissioned as part of this work programme and produced by the New Policy Institute. Additional work was also undertaken on the housing issues and priorities during COVID. A short report and examples of good practice are provided here. These reports are intended as a resource to support stakeholders in planning during the transition and recovery phase. However, they are also relevant to policy and decision-making as part of the ongoing response. The GLA have also commissioned the University of Manchester to undertake a rapid evidence review on inequalities in relation to COVID-19 and their effects on London.